GlassScriptPhysician profile
Harold A Johnson
NPI 1154327096
$8,574.20
in general payments reported to CMS, 2019-2025
59 companies · $2,433 in 2025
The $2,433 reported for 2025 was more than what 91% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $497 · 2020: $680 · 2021: $818 · 2022: $1,013 · 2023: $1,255 · 2024: $1,879 · 2025: $2,433.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,446 · Education: $121.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,445.99 |
| Education | $120.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novocure INC. | $1,175.04 | 2019-2025 | Optune, Optune Gio |
| Janssen Biotech, INC. | $940.70 | 2019-2025 | Darzalex, Talvey, Tecvayli |
| Merck Sharp & Dohme LLC | $721.88 | 2020-2025 | Keytruda, Keytruda Qlex, Welireg |
| Gt Medical Technologies, INC | $587.75 | 2022-2025 | Gammatile |
| Novartis Pharmaceuticals Corporation | $391.04 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $372.90 | 2020-2025 | Enhertu, Imfinzi, Lynparza |
| Incyte Corporation | $321.60 | 2019-2025 | Jakafi, Monjuvi, Pemazyre |
| Lilly USA, LLC | $307.27 | 2019-2025 | Verzenio, Jaypirca, Retevmo |
| Genzyme Corporation | $272.20 | 2019-2025 | |
| Genentech USA, INC. | $228.95 | 2021-2025 | Tecentriq, Phesgo, Polivy |
| Daiichi Sankyo INC. | $221.29 | 2024-2025 | Enhertu |
| Eisai INC. | $205.92 | 2020-2025 | |
| Emd Serono, INC. | $182.19 | 2020-2025 | Bavencio |
| Seagen INC. | $174.63 | 2019-2023 | Tukysa, Adcetris |
| Abbvie INC. | $162.04 | 2021-2025 |
Show all 59 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harold Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.